Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Qunibi
Wajeh
W
Muenz
Larry R
LR
D000085:Acetates / Q000627:therapeutic use*; D002114:Calcinosis / Q000188:drug therapy*; D017610:Calcium Compounds / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D011073:Polyamines / Q000627:therapeutic use*; D000069603:Sevelamer
D000085:Acetates; D017610:Calcium Compounds; D002614:Chelating Agents; D011073:Polyamines; D000069603:Sevelamer; C120662:calcium acetate